Harrow Health Inc (HROW) — Capital Reinvestment Ratio

Latest as of December 2025: 0.04x

Harrow Health Inc (HROW) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($8.41 Million) in capital expenditures ($341.00K). Check how tangible is Harrow Health Inc's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.04x
Capex / Operating Cash Flow

Operating Cash Flow

$8.41 Million
USD

Capital Expenditures

$341.00K
USD

Data as of

Dec 2025
Most recent filing

Harrow Health Inc Capital Reinvestment Ratio (2018–2025)

This chart tracks Harrow Health Inc's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Harrow Health Inc.

Annual Capital Reinvestment Ratio for Harrow Health Inc (2018–2025)

Year-by-year Capital Reinvestment Ratio for Harrow Health Inc from 2018 to 2025. See HROW free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.03x $43.86 Million $1.10 Million ▼ -99.9%
2023 39.73x $3.84 Million $152.55 Million ▲ +771.4%
2022 4.56x $1.71 Million $7.77 Million ▼ -18.7%
2021 5.61x $5.08 Million $28.51 Million ▲ +190.1%
2019 1.93x $950.00K $1.84 Million ▼ -39.7%
2018 3.21x $687.00K $2.20 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow